+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Development and validation of an analytical method for regorafenib and its metabolites in mouse plasma



Development and validation of an analytical method for regorafenib and its metabolites in mouse plasma



Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1090: 43-51



An analytical method was developed for measuring the effect of OATP1B2 deficiency on plasma levels of the kinase inhibitor regorafenib and its metabolites regorafenib-N-oxide, N-desmethyl-regorafenib-N-oxide, and regorafenib-N-β-glucuronide (RG) in mice. Compounds were separated by liquid chromatography and monitored by a triple quadrupole mass spectrometer in the selected reaction monitoring mode after positive electrospray ionization. All calibration curves were linear in the selected concentration range (R2 ≥ 0.99). The lower limit of quantification was 5 ng/mL for the four analytes. Within-day precisions, between-day precisions, and accuracies were 2.59-6.82%, 3.97-11.3%, and 94.5-111%, respectively. The identification and structure elucidation of RG, isolated from human urine, was performed by NMR. Compared with wild-type mice given regorafenib (10 mg/kg), deficiency of the drug transporter OATP1B2 in vivo had minimal effects on plasma levels of parent drug and the metabolite regorafenib-N-oxide, and N-desmethyl-regorafenib-N-oxide. However, the area under the curve and peak levels of RG were increased by 5.6-fold and 5.1-fold, respectively, in OATP1B2-knockout mice. In conclusion, our analytical method allowed accurate and precise quantitation of regorafenib and its main metabolites in mouse plasma, and is suitable for evaluation of transporter-dependent pharmacokinetic properties of these agents in vivo.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058009427

Download citation: RISBibTeXText

PMID: 29783173

DOI: 10.1016/j.jchromb.2018.05.005


Related references

Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 898: 121-129, 2012

Biogenic amines and their metabolites in mouse brain tissue: development, optimization and validation of an analytical HPLC method. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 878(29): 3003-3014, 2011

Development and Validation of an Analytical Method for Quantitation of Sulfolane in Rat and Mouse Plasma by GC-MS. Journal of Analytical Toxicology 2019, 2019

Development and validation of a sensitive LC/MS/MS method for the simultaneous determination of naloxone and its metabolites in mouse plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 879(25): 2663-2668, 2011

Development and validation of a UPLC-MS/MS analytical method for dofetilide in mouse plasma and urine, and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 172: 183-188, 2019

Development and Validation of an Analytical Method to Quantitate Tris(chloroisopropyl)phosphate in Rat and Mouse Plasma using Gas Chromatography with Flame Photometric Detection. Journal of Analytical Toxicology 2018, 2018

Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate. Biomarkers 8(3-4): 204-217, 2003

Cobalamin as an analytical tool for analysis of oxirane metabolites of 1,3-butadiene: development and validation of the method. Journal of Chromatography. a 1119(1-2): 246-250, 2006

Development and validation of an LC/electrospray MS method for AZT and its metabolites in plasma. Pharmaceutical Research (New York) 14(11 SUPPL ): S585, 1997

Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in Mice. Clinical and Translational Science 2019, 2019

Analytical method development for the simultaneous quantitation of dexmedetomidine and three potential metabolites in plasma. Journal Of Chromatography A. 762(1-2): 281-291, 1997

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma. Journal of Pharmaceutical Analysis 2(6): 492-498, 2012

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma. Journal of Pharmaceutical Analysis 2(6), 2012

Development and validation of analytical method for the estimation of lamivudine in rabbit plasma. Journal of Pharmaceutical Analysis 1(4): 251-257, 2011

Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 823(2): 69-74, 2005